Efficacy and Safety Study of Octafibrin for On-demand Treatment of Acute Bleeding and to Prevent Bleeding During and After Surgery

PHASE3CompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

September 30, 2014

Primary Completion Date

February 14, 2018

Study Completion Date

February 14, 2018

Conditions
Congenital Fibrinogen Deficiency
Interventions
DRUG

Octafibrin

Trial Locations (12)

33155

Miami Children's Hospital, Miami

Unknown

"Dept of Clinical Hematology for Hemorrhagic Diatheses and Anaemia, SHAT Joan Pavel", Sofia

St. John's Medical College Hospital, Bangalore

Sahyadri Specialty Hospital, Pune

Dept of Hematology, Christian Medical College, Vellore

Seyed Al Shohada Hospital, Isfahan

Dastgheib Hospital, Shīrāz

Hotel-Dieu de France, Beirut

Haematological Scientific Center of Ministry of Healthcare of the Russian Federation, Moscow

Centre of Excellence in Thrombosis & Hemostasis, King Saud University, Riyadh

Dept of Haematology, Ege University Children's Hospital, Izmir

Centre for Haemostasis & Thrombosis, St Thomas' Hospital, London

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Octapharma

INDUSTRY